2022 - Research.com Best Scientist Award
1999 - Fellow of the American Association for the Advancement of Science (AAAS)
1984 - Fellow of John Simon Guggenheim Memorial Foundation
Member of the Association of American Physicians
Virology, Immunology, Virus, Acquired immunodeficiency syndrome and Drug resistance are his primary areas of study. His research investigates the connection between Virology and topics such as Molecular biology that intersect with problems in Cell culture. His study in Viral load, Viral disease, Viremia, Lentivirus and Virus latency falls within the category of Immunology.
His Virus research incorporates elements of T cell, Peripheral blood mononuclear cell, Antibody and Sexual transmission. In Acquired immunodeficiency syndrome, Douglas D. Richman works on issues like Pharmacotherapy, which are connected to MEDLINE. His research investigates the link between Drug resistance and topics such as Drug that cross with problems in Disease.
Douglas D. Richman mainly focuses on Virology, Immunology, Virus, Acquired immunodeficiency syndrome and Zidovudine. His studies in Virology integrate themes in fields like Antibody, Drug resistance and Reverse transcriptase. Immunology and Peripheral blood mononuclear cell are frequently intertwined in his study.
His Virus research includes themes of RNA, Cell culture, In vitro and Molecular biology. His Acquired immunodeficiency syndrome study combines topics in areas such as Clinical trial, Internal medicine, Pharmacotherapy, Disease and Cohort. His research in Zidovudine intersects with topics in Lamivudine, AIDS-related complex, Indinavir and Chemotherapy.
Douglas D. Richman mostly deals with Virology, Immunology, Viral load, Peripheral blood mononuclear cell and Viral replication. His study in Virology focuses on Virus and Viremia. His work in Immunology addresses issues such as Transcription, which are connected to fields such as Asymptomatic.
His Viral load research includes elements of Internal medicine, Interquartile range, Cohort study, Genotype and Drug resistance. His Cohort study research includes elements of Acquired immunodeficiency syndrome, Incidence and Cohort. His research in Peripheral blood mononuclear cell intersects with topics in Cytomegalovirus and Transplantation.
Douglas D. Richman focuses on Immunology, Virology, Viral load, Viral replication and Peripheral blood mononuclear cell. His study involves Immune system, Virus latency, CD8, T cell and Antibody, a branch of Immunology. Virus and Emtricitabine are among the areas of Virology where the researcher is concentrating his efforts.
The concepts of his Viral load study are interwoven with issues in Cohort study, Resistance mutation, Lopinavir, Bone marrow and Lentivirus. His Viral replication research integrates issues from Asymptomatic and Transcription. Douglas D. Richman studied Peripheral blood mononuclear cell and RNA that intersect with DNA, CXCR3, In vitro, IL-2 receptor and Lymphatic system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial.
Margaret A Fischl;D. D. Richman;M. H. Grieco;M. S. Gottlieb.
The New England Journal of Medicine (1987)
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
Diana Finzi;Monika Hermankova;Theodore Pierson;Lucy M. Carruth.
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
Joseph K. Wong;Marjan Hezareh;Huldrych F. Günthard;Diane V. Havlir.
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
R M Gulick;J W Mellors;D Havlir;J J Eron.
The New England Journal of Medicine (1997)
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy
Brendan A. Larder;Graham Darby;Douglas D. Richman.
Update of the Drug Resistance Mutations in HIV-1.
Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard.
Topics in HIV medicine : a publication of the International AIDS Society, USA (2008)
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.
Victor Appay;P. Rod Dunbar;Margaret Callan;Paul Klenerman.
Nature Medicine (2002)
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter
Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth.
The New England Journal of Medicine (1990)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Douglas D. Richman;Terri Wrin;Susan J. Little;Christos J. Petropoulos.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Susan J. Little;Sarah Holte;Jean Pierre Routy;Eric S. Daar.
The New England Journal of Medicine (2002)
(Impact Factor: 1.679)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: